Acadia Pharmaceuticals (ACAD) Change in Cash (2010 - 2026)

Acadia Pharmaceuticals' Change in Cash history runs 17 years deep, the most recent figure standing at $104.5 million for Q1 2026.

• In Q1 2026, Change in Cash rose 202.58% year-over-year to $104.5 million; the TTM figure through Mar 2026 stood at $63.6 million (up 298.67% YoY), while the FY2025 annual figure was -$142.8 million, down 206.64% from the prior year.
• Change in Cash was $104.5 million for Q1 2026 at Acadia Pharmaceuticals, up from -$81.9 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $176.0 million in Q1 2023 to a low of -$180.6 million in Q2 2023.
• Historically, Change in Cash has averaged $8.1 million across 5 years, with a median of $4.4 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Change in Cash soared 366.86% in 2022, then plunged 733.35% in 2025.
• A 5-year view of Change in Cash shows it stood at -$40.0 million in 2022, then soared by 326.18% to $90.5 million in 2023, then surged by 81.77% to $164.4 million in 2024, then plunged by 149.82% to -$81.9 million in 2025, then soared by 227.57% to $104.5 million in 2026.
• The last three Change in Cash figures came in at $104.5 million (Q1 2026), -$81.9 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.